In the pharmaceutical discovery process, understanding a drug’s residence time—the duration a molecule remains bound to its ...
PRINCETON, N.J., June 28, 2022 (GLOBE NEWSWIRE) -- Certara (Nasdaq: CERT), a global leader in biosimulation, today announced the release of Simcyp Discovery Simulator, a new software designed for ...
Turbine, a simulation-based drug discovery company today announced the closing of an institutional financing round led by Delin Ventures. The seed fund will be used to redesign the failure-prone ...
Innovative Science in the Areas of Small Molecule Modeling, Fragment-Based Design, Transmembrane Proteins, and Antibody Modeling Sets New Standard for Life Science Research and Development SAN DIEGO, ...
— Companies will co-develop inhibitors of a dark kinase target (NEK1) identified for cancer dependency by Turbine’s Simulated Cell™ platform — LONDON & BUDAPEST, Hungary & NEW YORK--(BUSINESS ...
LONDON & BUDAPEST, Hungary--(BUSINESS WIRE)--Turbine, a simulation-based drug discovery company today announced the closing of an institutional financing round led by Delin Ventures. The seed fund ...
A simulation-based drug discovery company, Turbine, has announced the closing of an institutional funding round worth EUR 3 million (US $3.3 million), which will be used to redesign the oncology drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback